Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pathology, Research and Practice

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.prp.2017.12.019PMID 29487008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis.

  2017cited by this paper
• Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

  2017cited by this paper
• Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds

  2017cited by this paper
• Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer

  2016cited by this paper
• Histologic prognostic markers in stage IIA colorectal cancer: a comparative study

  2016cited by this paper
• Poorly differentiated clusters with larger extents have a greater impact on survival: a semi-quantitative pathological evaluation for 239 patients with non-mucinous pT2-3 colorectal carcinoma

  2015cited by this paper
• Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort

  2015cited by this paper
• Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study

  2015cited by this paper
• Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis

  2015cited by this paper
• Clinicopathologic Impacts of Poorly Differentiated Cluster-Based Grading System in Colorectal Carcinoma

  2014cited by this paper
• Site-specific Tumor Grading System in Colorectal Cancer: Multicenter Pathologic Review of the Value of Quantifying Poorly Differentiated Clusters

  2014cited by this paper
• Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer

  2014cited by this paper
• Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: a proposal for a change in terminology.

  2014cited by this paper
• Should the grading of colorectal adenocarcinoma include microsatellite instability status?

  2014cited by this paper
• Tumour budding is a reproducible index for risk stratification of patients with Stage II colon cancer

  2014cited by this paper
• Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

  2013cited by this paper
• AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?

  2013cited by this paper
• ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

  2012cited by this paper
• Tumor Budding is an Independent Predictor of Outcome in AJCC/UICC Stage II Colorectal Cancer

  2012cited by this paper
• Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy

  2012cited by this paper
• Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading

  2012cited by this paper
• Number of harvested lymph nodes is the main prognostic factor in Stage IIa colorectal cancer patients

  2012cited by this paper
• New Criteria for Histologic Grading of Colorectal Cancer

  2012cited by this paper
• Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status

  2011cited by this paper
• Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer

  2009cited by this paper
• Tumor Budding as an Index to Identify High-Risk Patients with Stage II Colon Cancer

  2008cited by this paper
• Interobserver agreement in grading of colorectal cancers—findings from a nationwide web‐based survey of histopathologists

  2008cited by this paper
• Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy

  2008cited by this paper
• American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

  2004cited by this paper
• Carcinoma of the colon and rectum.

  1962cited by this paper

• Society of surgical oncology medical student & trainee primer for non-HPB GI oncology

  2026cites this paper
• FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinoma.

  2025cites this paper
• Tumor Budding in Colorectal Carcinoma: A Tertiary Care Center Study

  2025cites this paper
• Independent prognostic significance of tumor budding and poorly differentiated clusters in Brazilian patients with stage II colorectal cancer

  2025cites this paper
• Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer

  2025cites this paper
• Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosis

  2025cites this paper
• A Preoperative CT-based Multiparameter Deep Learning and Radiomic Model with Extracellular Volume Parameter Images Can Predict the Tumor Budding Grade in Rectal Cancer Patients.

  2025cites this paper
• A Combined Scoring System for Tumor Budding and Poorly Differentiated Clusters in Colorectal Cancer: A Retrospective Study

  2025cites this paper
• Effects of tumour budding on adjuvant chemotherapy in colorectal cancer

  2024cites this paper
• Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancer

  2024cites this paper
• The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update

  2024cites this paper
• Tumor Budding, Poorly Differentiated Clusters, and Stroma Percentage in Uterine Endometrioid Carcinomas Are Morphologic Findings Associated With Adverse Clinical Outcomes

  2024cites this paper
• Combining immunoscore and tumor budding in colon cancer: an insightful prognostication based on the tumor-host interface

  2024cites this paper
• The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations.

  2024cites this paper
• Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study

  2024cites this paper
• Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial

  2024cites this paper
• Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts.

  2024cites this paper
• Tumor budding in gastric cancer

  2023cites this paper
• Tumor Budding Assessment in Colorectal Carcinoma

  2023cites this paper
• Prognostic Value of Tumor Budding for Early Breast Cancer

  2023cites this paper
• Facteurs histopronostiques et biomarqueurs pour une prise en charge personnalisée du cancer colorectal

  2023cites this paper
• Prognostic Factors Among Colonic Adenocarcinomas Invading Into the Muscularis Propria

  2023cites this paper
• Partial mesorectal excision can be a primary option for middle rectal cancer: a propensity score–matched retrospective analysis

  2023cites this paper
• A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer

  2022cites this paper
• Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease

  2022cites this paper
• Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).

  2022cites this paper
• Significance of tumor budding in colorectal carcinoma – A tertiary care center study

  2022cites this paper
• The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer

  2022cites this paper
• Poorly differentiated cluster grade-a vital predictor for lymph node metastasis and oncological outcomes in patients with T1 colorectal cancer: a retrospective study

  2022cites this paper
• Prognostic Ability of Tumor Budding Outperforms Poorly Differentiated Clusters in Gastric Cancer

  2022cites this paper
• Adjuvant chemotherapy in stage II and III colon cancer: the role of the “budding and TILs-(tumor-infiltrating lymphocytes) combination” as tumor-host antagonists

  2021cites this paper
• Predicting Tumor Budding Status in Cervical Cancer Using MRI Radiomics: Linking Imaging Biomarkers to Histologic Characteristics

  2021cites this paper
• Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery

  2021cites this paper
• Prognostic significance of tumor budding, poorly differentiated cluster, and desmoplastic reaction in endometrioid endometrial carcinomas

  2021cites this paper
• Morphology Matters

  2021cites this paper
• Tumor budding as a predictive marker for 5-fluorouracil response in adjuvant-treated stage III colorectal cancer

  2021cites this paper
• Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?

  2021cites this paper
• Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon Cancer

  2021influential citation
• Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.

  2020cites this paper
• Clinicopathological and molecular features of sporadic colorectal cancers with DNA mismatch repair deficiency: A single center experience

  2020cites this paper
• Comment on Jun, S.Y.; et al. “Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma” Cancers 2020, 12, 2199

  2020cites this paper
• Tumour budding in solid cancers

  2020cites this paper
• A comprehensive overview of promising biomarkers in stage II colorectal cancer.

  2020cites this paper
• Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer

  2020cites this paper
• The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer

  2020influential citation
• Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer

  2020cites this paper
• Poorly differentiated clusters in colorectal cancer: a current review and implications for future practice

  2020influential citation
• Novel Internationally Verified Method Reports Desmoplastic Reaction as the Most Significant Prognostic Feature For Disease-specific Survival in Stage II Colorectal Cancer

  2019cites this paper
• TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma

  2019cites this paper
• Study of histopathologic parameters to define the prognosis of stage II colon cancer

  2019cites this paper
• Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma.

  2019cites this paper
• Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining

  2019cites this paper
• Desmoplastic Reaction as the Most Significant Prognostic Feature For Disease-specific Survival in Stage II Colorectal Cancer

  2019cites this paper
• Separation of low versus high grade Crohn's disease-associated small bowel carcinomas is improved by invasive front prognostic marker analysis.

  2019cites this paper
• (Pro)renin Receptor Expression Increases throughout the Colorectal Adenoma—Adenocarcinoma Sequence and It Is Associated with Worse Colorectal Cancer Prognosis

  2019cites this paper
• World Journal of Gastrointestinal Surgery W

  year unknowncites this paper